Booming Pharma Industry of India

During the past decade India has emerged as a global powerhouse, playing a pivotal role in providing affordable and high-quality medicines worldwide.

The Indian pharmaceutical industry exports medicines to more than 200 countries across the world including those with Stringent Regulatory Authorities.

The Indian pharma industry commands a significant share of over 20% in the global medicine supply chain. Notably, the industry has played a pivotal role in elevating India to the esteemed status of the “Pharmacy of the World.”

Almost 70% of the vaccine requirements of the World Health Organization (WHO) are also met by India.

India’s pharmaceutical industry remained one of the fastest-growing industries due to its huge demand. In 2023, the sector gained momentum in forming a Global Alliance with many countries. The country has maintained its position as 3rd largest producer of pharmaceuticals in terms of volume.

The pharma sector has sustained its rise and is expected to grow US dollars 100 billion by 2025. Besides this, India is also known to be the second largest contributor to the global biotech and pharmaceutical workforce. This has positioned India to lead in the coming years with the growing support of the government to hit 130 million dollars by the end of 2030.

India has grown tremendously due to its high quality and high affordability offerings of pharmaceuticals. An economic survey of 2022-2023 showcase that India is the largest provider of generic medications worldwide. Successfully occupying a 20% share in the Global supply by volume, has led to the increased production and sales of generic medications in 2023.

It is also a leading country for manufacturing vaccines holding a market share of 60%.  It contributes 8% to the Global API industry by manufacturing 500 APIs from its quality API manufacturers.

Being the largest country to supply generic medications, it has 60,000 different generic brands that offer different therapeutic categories. This accounts for 20% of the Global supply chain for generics.

India is also well known for providing affordable treatment for HIV. Through this, it plays a pivotal role in shaping India’s trajectory and reputation throughout the world.

These highlights show India’s transformation which anticipates a long-term growth of the pharma industry in the coming years.

Several schemes have helped sustain the growth of the sector. The government has implemented National Pharmaceutical policy- the policy serves as a comprehensive framework to combat challenges through 5 key pillars. These are Rearing Global Pharmaceutical Leadership, Promoting Self-Reliance, Advancing Health Equity and Accessibility, and Improving Regulatory Efficiency. India aims to enhance its industrial ecosystem with this definitive policy.

Also through liberalized Foreign Direct Investment (FDI), the government has launched a policy to attracting FDI’s in the field.

Also through Human Resource Development a skilled workforce through research and development for the medical device sector is planned. Around 5000 students were trained for 3 years to remove India’s dependency on importing high and medical devices.

Scheme for Promotion of Research and Innovation launched in 2023, outlays the financial of 5000 crores. This financial investment was promoted to transform the Indian Pharma medical sector with technical advancement and innovation through in-depth R&D.

Looking forward to 2024 Indian pharma growth is expected to reach 130 billion dollars by 2030. With the widespread of new technology advancements, the industry has experienced rapid and radical change in a few years. Thus the sector is expected to grow at CAGR 22.4 % in the future.

Observing the sector’s rapid growth, the government has also shown a significant contribution to encouraging 2000 startups in the field of Life Science. In addition to this, big pharma companies are now allocating 5 to 10% of their company’s revenue to R&D for future biotech startups hoping it will attract global partners.

As per recent estimates, the Indian pharmaceutical Industry includes a network of 3,000 drug companies and 10,500 manufacturing units. Promotion of medical devices parks, strengthening infrastructure facilities and robust pricing policies are key steps taken in the right direction.

India’s pharma exports have increased 138 per cent in April-October 2022-23 compared to the same period of 2013-14 when the country became the pharmacy for the world.

India’s pharma exports witnessed a growth of 138 per cent since April-October 2013-14, from Rs 37,987.68 crores in 2013-14 to Rs 90,324.23 crores in 2021-22.

The Indian vaccine industry developed Covid vaccine with indigenous technology in collaboration with India’s research institutions like Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV) within shortest time on par with highly developed countries like America and EU. India provided 115 million doses of vaccines to more than 97 countries.

As part of the trade agreements, India has also signed a cooperation agreement with the UAE and Australia which will give enhanced access to Indian pharma products to these markets. The massive drug and vaccine production during the pandemic also underlined the capability of the Indian pharma industry as there were no complaints about the quality of medicines. In any case, the government has a zero-tolerance policy for sub-par quality drugs and takes stringent actions against the companies involved in such malpractices. From being an import-dependent sector to a self-reliant powerhouse, with a leading global exporter of medicines, have evolved the pharmaceutical sector. India strive to achieve new milestones, and more achievements in the years to come.

The government recognises the vital role of the pharma sector in realising India’s vision of Atmanirbhar Bharat. The pharma industry is now ready to expand its innovation, research, and development capabilities to offer cutting-edge products at competitive, affordable prices. India is marching ahead in the field of research and innovation with the government now opening its research facilities to all, including the private sector.

The government’s commitment to the growth of the pharma industry is also evident in Vision Pharma 2047 which seeks to usher in an enabling policy framework for the sector to unleash its huge potential for the next two decades and half. India’s pharma industry has a formidable capacity and Vision Pharma 2047 seeks to leverage that to help the country become a global leader in manufacturing affordable, innovative, and quality pharmaceuticals and medical devices, and a leader in innovation and research. (Pharma News)

The post Booming Pharma Industry of India appeared first on DailyNews.